Dr Reddy's gets tentative US FDA nod for generic HIV prevention
Nov 2, 2026
Dr Reddy's received tentative FDA approval for a generic HIV prevention drug priced at $40 annually, significantly lower than the branded version. This milestone enables accelerated global rollout in low- and middle-income countries starting in 2026.